Predicting taxane-induced peripheral neuropathy by nailfold capillaroscopy: The CAPNEU pilot study
Supportive Care in Cancer · 2026-08 · 34 (8)
DOI: 10.1007/s00520-026-11043-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 26.07.2026. Verfasst von Ali Alkan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Medical Oncology, Muğla Sıtkı Koçman University, KötekliMh. MarmarisYoluBulvarı No, 55 Menteşe, 48000, Muğla, Türk…. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Breast Neoplasms, Microscopic Angioscopy, Taxoids. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Taxane-induced peripheral neuropathy (TIPN) remains a frequent, dose-limiting toxicity in breast cancer, and reliable pre-treatment predictors are lacking. Nailfold capillaroscopy (NFC) offers a non-invasive window into systemic microvascular morphology, which may reflect vascular susceptibility relevant to neuropathy risk. The objective of the study was to evaluate whether baseline NFC morphology is associated with taxane-related neuropathy severity and symptom burden, and to explore ROC-derived thresholds of NFC parameters for identifying clinically significant neuropathy.
Methods
In this pilot cohort (N = 48) of breast cancer patients receiving taxane-based regimens (docetaxel [DOC], paclitaxel [PAC], or carboplatin–paclitaxel [CPAC]), baseline NFC parameters—capillary density (CD), capillary width (CW), capillary loop diameter (CLD), and capillary length (CL)—were recorded. Neuropathy outcomes were assessed longitudinally using NCI-CTCAE score and EORTC QLQ-CIPN20. Regimen-stratified associations were examined using Spearman’s correlation. ROC analyses were conducted in the overall cohort using NCI ≥ 2 vs 0–1 as the binary endpoint; optimal cut-offs were defined by Youden’s index.
Results
Regimen-specific patterns were observed. In CPAC (N = 13), CD correlated with NCI (ρ = 0.567, p = 0.043) and CIPN20 (ρ = 0.608, p = 0.028). In PAC (N = 16), no significant correlations were found between NFC parameters and neuropathy outcomes (all p > 0.05), although CIPN20 and NCI remained strongly correlated (ρ = 0.778, p < 0.001) and CLD–NCI showed a trend (ρ = 0.486, p = 0.056). In DOC (N = 19), CL correlated with NCI (ρ = 0.509, p = 0.026) and CIPN20 (ρ = 0.484, p = 0.036), while CW was inversely correlated with CIPN20 (ρ = − 0.510, p = 0.026). In overall ROC analyses, optimal thresholds for predicting NCI ≥ 2 were CD ≥ 8.5 capillaries/mm (sensitivity 77.3%, specificity 42.3%), CW ≥ 31.0 (90.9%, 26.9%), CLD ≥ 18.45 (90.9%, 42.3; highest Youden index 0.332), and CL ≥ 160.1 (72.7%, 46.2).
Conclusions
Baseline NFC morphology demonstrated regimen-dependent associations with taxane-related neuropathy outcomes and yielded exploratory ROC thresholds for identifying clinically significant neuropathy (NCI ≥ 2). CLD showed the strongest overall discrimination, while subgroup analyses highlighted distinct candidate markers (CD in CPAC; CL in DOC). These findings are hypothesis-generating and warrant validation in larger, independent cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Medical Oncology, Muğla Sıtkı Koçman University, KötekliMh. MarmarisYoluBulvarı No, 55 Menteşe, 48000, Muğla, Türkiye. alkanali@yahoo.com.
- Faculty of Medicine, Department of Rheumatology, Muğla Sıtkı Koçman University, Muğla, Türkiye.
- Faculty of Medicine, Department of Neurology, Muğla Sıtkı Koçman University , Muğla, Türkiye.
- Faculty of Medicine, Department of Medical Oncology, Muğla Sıtkı Koçman University, KötekliMh. MarmarisYoluBulvarı No, 55 Menteşe, 48000, Muğla, Türkiye.
Zitieren
APA
Alkan, A., Ersoy, M., Cenikli, U., Tarhan, E. F., & Tanrıverdi, Ö. (2026). Predicting taxane-induced peripheral neuropathy by nailfold capillaroscopy: The CAPNEU pilot study. Supportive Care in Cancer, 34(8). https://doi.org/10.1007/s00520-026-11043-9
Vancouver
Alkan A, Ersoy M, Cenikli U, Tarhan EF, Tanrıverdi Ö. Predicting taxane-induced peripheral neuropathy by nailfold capillaroscopy: The CAPNEU pilot study. Supportive Care in Cancer. 2026;34(8). doi:10.1007/s00520-026-11043-9
BibTeX
@article{Alkan2026,
author = {Alkan, Ali and Ersoy, Melike and Cenikli, Utku and Tarhan, Emine Figen and Tanrıverdi, Özgür},
title = {Predicting taxane-induced peripheral neuropathy by nailfold capillaroscopy: The CAPNEU pilot study},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {8},
doi = {10.1007/s00520-026-11043-9}
}
EUVIMED